Abnormalities - Aicardi Syndrome - Amniotic Band Syndrome - Anencephaly
- Anencephaly - Angelman Syndrome - Angelman Syndrome - Angelman
Syndrome - Bannayan-Zonana Syndrome - Barth Syndrome - Basal Cell
Nevus Syndrome - Basal Cell Nevus Syndrome - Beckwith-Wiedemann
Syndrome - Beckwith-Wiedemann Syndrome - Beckwith-Wiedemann Syndrome
- Bloom Syndrome - Cat Eye Syndrome - Cerebral Gigantism - CHARGE
Syndrome - Chromosome 16 Abnormalities - Chromosome 18 Abnormalities
- Chromosome 20 Abnormalities - Chromosome 22 Abnormalities - Chromosome
Disorders - Chromosome Disorders - Congenital, Hereditary, and Neonatal
Diseases and Abnormalities - Costello Syndrome - Cri-du-Chat Syndrome
- Cri-du-Chat Syndrome - Cri-du-Chat Syndrome - Cystic Fibrosis
- Cystic Fibrosis - De Lange Syndrome - De Lange Syndrome - De Lange
Syndrome - Distal Trisomy 10q - Down Syndrome - Down Syndrome -
Down Syndrome - Ectodermal Dysplasia - Ectodermal Dysplasia - Ectodermal
Dysplasia - Ectodermal Dysplasia - Ectodermal Dysplasia - Fetal
Alcohol Syndrome - Fetal Diseases - Fetofetal Transfusion - Fragile
X Syndrome - Fragile X Syndrome - Fragile X Syndrome - Fragile X
Syndrome - Freeman-Sheldon Syndrome - Gastroschisis - Genetic Diseases,
Inborn - Hernia, Umbilical - Holoprosencephaly - Holoprosencephaly
- Holoprosencephaly - Holoprosencephaly - Holoprosencephaly - Incontinentia
Pigmenti - Incontinentia Pigmenti - Incontinentia Pigmenti - Infant,
Newborn, Diseases - Ivemark Syndrome - Jacobsen Syndrome - Jaundice,
Neonatal - Klinefelter Syndrome - Klinefelter Syndrome - Klinefelter
Syndrome - Larsen Syndrome - Laurence-Moon Syndrome - Lissencephaly
- Microcephaly - Monosomy 9p- - Musculoskeletal Abnormalities -
Nail-Patella Syndrome - Neurofibromatoses - Neurofibromatoses -
Neuronal Ceroid-Lipofuscinosis - Neuronal Ceroid-Lipofuscinosis
- Noonan Syndrome - Ochoa Syndrome (Urofacial Syndrome, Hydronephrosis
with Peculiar Facial Expression; not on MeSH) - Oculocerebrorenal
Syndrome - Oculocerebrorenal Syndrome - Oculocerebrorenal Syndrome
- Oculocerebrorenal Syndrome - Oculocerebrorenal Syndrome - Pallister-Killian
Syndrome - Prader-Willi Syndrome - Prader-Willi Syndrome - Prader-Willi
Syndrome - Proteus Syndrome - Proteus Syndrome - Prune Belly Syndrome
- Rett Syndrome - Rett Syndrome - Rett Syndrome - Robinow Syndrome
- Rubinstein-Taybi Syndrome - Rubinstein-Taybi Syndrome - Rubinstein-Taybi
Syndrome - Rubinstein-Taybi Syndrome - Schizencephaly - Situs Inversus
- Smith-Lemli-Opitz Syndrome - Smith-Lemli-Opitz Syndrome - Smith-Lemli-Opitz
Syndrome - Smith-Magenis Syndrome - Sturge-Weber Syndrome - Syphilis,
Congenital - Trichothiodystrophy - Triple-X Females - Trisomy 13
(Patau Syndrome; not on MeSH) - Trisomy 9 - Trisomy 9 - Turner Syndrome
- Turner Syndrome - Turner Syndrome - Twins, Conjoined - Usher Syndrome
- Waardenburg's Syndrome - Werner Syndrome - Wolf-Hirschhorn Syndrome
Department of Pediatric - News - All children deserve our attention Info

tums-ped.org v 4_3

aUL = The maximum level of daily nutrient intake that is likely to pose no risk of adverse effects. Unless otherwise specified, the UL represents total intake from food, water, and supplements. Due to lack of suitable data, ULs could not be established for thiamine, riboflavin, vitamin B12, pantothenic acid, and biotin. In the absence of ULs, extra caution may be warranted in consuming levels above recommended intakes.
bThe UL for magnesium represents intake from a pharmacological agent only and does not include intake from food and water.
cThe ULs for niacin and folate apply to synthetic forms obtained from supplements, fortified foods, or a combination of the two.
dND: Not determinable due to lack of data of adverse effects in this age group and concern with regard to lack of ability to handle excess amounts. Source of intake should be from food only to prevent high levels of intake.